Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Takeuchi, H. Matsumura, Y. Kano (2002)
Cloning and Expression in Escherichia coli of a Gene, hup, Encoding the Histone-like Protein HU of Bifidobacterium longumBioscience, Biotechnology, and Biochemistry, 66
K. Wong, John Feeley, R. Northrup, And Forlines (1974)
Vi Antigen from Salmonella typhosa and Immunity Against Typhoid Fever I. Isolation and Immunologic Properties in AnimalsInfection and Immunity, 9
Weiwen Jiang, D. Pisetsky (2003)
Enhancing immunogenicity by CpG DNA.Current opinion in molecular therapeutics, 5 2
Sang-Woon Choi, S. Friso, Mary Keyes, J. Mason (2005)
Folate supplementation increases genomic DNA methylation in the liver of elder ratsBritish Journal of Nutrition, 93
Michael McClelland, K. Sanderson, J. Spieth, S. Clifton, P. Latreille, L. Courtney, S. Porwollik, Johar Ali, M. Dante, Feiyu Du, Shunfang Hou, Daniel Layman, S. Leonard, Christine Nguyen, Kelsi Scott, Andrea Holmes, Neenu Grewal, E. Mulvaney, E. Ryan, Hui Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, R. Wilson (2001)
Complete genome sequence of Salmonella enterica serovar Typhimurium LT2Nature, 413
M. Rossi, Patrizia Brigidi, D. Matteuzzi (1998)
Improved cloning vectors for Bifidobacterium spp.Letters in Applied Microbiology, 26
L. Strindelius, M. Filler, I. Sjöholm (2004)
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.Vaccine, 22 27-28
K. Lammers, P. Brigidi, B. Vitali, P. Gionchetti, F. Rizzello, E. Caramelli, D. Matteuzzi, M. Campieri (2003)
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.FEMS immunology and medical microbiology, 38 2
S. Raghavan, J. Nyström, M. Fredriksson, J. Holmgren, A. Harandi (2003)
Orally Administered CpG Oligodeoxynucleotide Induces Production of CXC and CC Chemokines in the Gastric Mucosa and Suppresses Bacterial Colonization in a Mouse Model of Helicobacter pylori InfectionInfection and Immunity, 71
J. Seegers (2002)
Lactobacilli as live vaccine delivery vectors: progress and prospects.Trends in biotechnology, 20 12
H. Matsumura, A. Takeuchi, Y. Kano (1997)
Construction of Escherichia coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A.Bioscience, biotechnology, and biochemistry, 61 7
R. Black, M. Levine, C. Young, J. Rooney, S. Levine, M. Clements, Sylvia O'Donnell, T. Hugues, R. Germanier (1983)
Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.Developments in biological standardization, 53
M. Levine, C. Ferreccio, Paulina Abrego, O. Martin, Edith Ortiz, S. Cryz (1999)
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.Vaccine, 17 Suppl 2
C. Ferreccio, Edith Ortiz, S. Cryz, MyronM. Levine (1990)
Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trialThe Lancet, 336
D. Canh, F. Lin, V. Thiem, D. Trach, N. Trong, N. Mao, S. Hunt, R. Schneerson, J. Robbins, C. Chu, J. Shiloach, D. Bryla, M. Bonnet, D. Schulz, S. Szu (2004)
Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese ChildrenInfection and Immunity, 72
Helen Garmory, K. Brown, R. Titball (2002)
Salmonella vaccines for use in humans: present and future perspectives.FEMS microbiology reviews, 26 4
Toshiyuki Nakamura, Takayuki Sasaki, M. Fujimori, K. Yazawa, Y. Kano, J. Amano, S. Taniguchi (2002)
Cloned Cytosine Deaminase Gene Expression of Bifidobacterium longum and Application to Enzyme/Pro-drug Therapy of Hypoxic Solid TumorsBioscience, Biotechnology, and Biochemistry, 66
M. Moors, Liwu Li, S. Mizel (2001)
Activation of Interleukin-1 Receptor-Associated Kinase by Gram-Negative FlagellinInfection and Immunity, 69
J. Kurmann, J. Rašić, R. Robinson (1991)
The health potential of products containing bifidobacteria.
G. Gibson, A. McCartney, R. Rastall (2005)
Prebiotics and resistance to gastrointestinal infectionsBritish Journal of Nutrition, 93
T. Ohta, S. Nakatsugi, K. Watanabe, T. Kawamori, F. Ishikawa, M. Morotomi, S. Sugie, T. Toda, T. Sugimura, K. Wakabayashi (2000)
Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones.Carcinogenesis, 21 5
E. Engels, M. Falagas, Joseph Lau, M. Bennish (1998)
Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicityBMJ, 316
J. Zhou, H. Gill (2005)
Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.International journal of food microbiology, 103 1
Kunihito Tanaka, Kazuya Samura, Y. Kano (2005)
Structural and Functional Analysis of pTB6 from Bifidobacterium longumBioscience, Biotechnology, and Biochemistry, 69
(2004)
Global typhoid burden refined
P. Scalabrini, M. Rossi, P. Spettoli, D. Matteuzzi (1998)
Characterization of Bifidobacterium strains for use in soymilk fermentation.International journal of food microbiology, 39 3
G. Tannock (1999)
Identification of lactobacilli and bifidobacteria.Current issues in molecular biology, 1 1-2
M. Saxelin, S. Tynkkynen, T. Mattila-Sandholm, W. Vos (2005)
Probiotic and other functional microbes: from markets to mechanisms.Current opinion in biotechnology, 16 2
B. Cookson, M. Bevan (1997)
Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice.Journal of immunology, 158 9
Background A critical component of the host defense against enteric infections is the immunological response of the mucosal membrane, a major starting point of infectious disease, such as typhoid fever. The mucosal immune system consists of an integrated network of lymphoid tissues, mucous membrane‐associated cells, and effector molecules. In the present study, we developed a recombinant Bifidobacterium animalis (B. animalis) genetically modified with the Salmonella flagellin gene for mucosal immunization as an oral typhoid vaccine. Methods We constructed an oral vaccine against Salmonella typhimurium, consisting of recombinant B. animalis containing the flagellin gene of Salmonella. The recombinant B. animalis was administered orally to mice every other day for 6 weeks. Anti‐flagellin antibodies in the serum and stools were measured by enzyme‐linked immunosorbent assay (ELISA). Results We detected significantly higher levels of flagellin‐specific IgA in the serum and stools of the mice treated with the recombinant B. animalis containing the flagellin gene than was seen in those treated with parental B. animalis. Conclusions Our findings suggest that an oral vaccination using recombinant B. animalis genetically modified with the flagellin gene of Salmonella may be effective against Salmonella infections. Copyright © 2006 John Wiley & Sons, Ltd.
Journal of Gene Medicine – Wiley
Published: Nov 1, 2006
Keywords: Bifidobacterium animalis ; mucosal vaccine; Salmonella typhimurium ; flagellin
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.